Department of Internal Medicine III, Clinical Division of Endocrinology and Metabolism, Unit of Gender Medicine, Medical University of Vienna, Währinger Gürtel 18-20, 1090, Vienna, Austria.
Section for Science of Complex Systems, CeMSIIS, Medical University of Vienna, Spitalgasse 23, 1090, Vienna, Austria.
Wien Klin Wochenschr. 2022 Jan;134(1-2):1-6. doi: 10.1007/s00508-021-01903-1. Epub 2021 Jul 5.
Testosterone plays an important role in the regulation of glucose metabolism. While earlier studies have shown that it has a protective effect in males, unfavorable effects of testosterone on glucose metabolism have been reported in females; however, whether there is a sex-specific relationship between testosterone and glucose metabolism in patients with prediabetes has not been investigated in detail hitherto.
This cross-sectional analysis investigated 423 males and 287 females with diagnosed prediabetes. Detailed assessment of their metabolic profiles was performed, including a 2‑h oral glucose tolerance test (OGTT), HbA1c levels, calculation of insulin resistance with homeostatic model assessment for insulin resistance (HOMA-IR), assessment of lipid metabolism, anthropometric parameters and the fatty liver index (FLI). By using Spearman's correlation test, we investigated the sex-specific relationship between testosterone and metabolism in the prediabetic individuals.
In the present study, prediabetic females (mean age 58.6 years, confidence interval [CI: 57.6 y; 59.5 y]) were characterized by lower fasting plasma glucose levels (104.2 mg/dl [CI: 103.0 mg/dl; 105.4 mg/dl] vs. 106.9 mg/dl [CI: 106.0 mg/dl; 107.8 mg/dl]) and a lower FLI (49.5 [CI: 45.7; 53.2] vs. 58.8 [CI: 55.8; 61.8]), but presented with a higher risk of developing manifest type 2 diabetes in the next 10 years (FINDRISK score: 17.6 [CI: 17.1; 18.1] vs. 16.1 [CI: 15.7; 16.5]) when compared to prediabetic males (mean age: 58.04 years [CI: 57.0 y; 59.1 y]). Testosterone was negatively related to insulin resistance (HOMA-IR: Spearman's ρ: -0.33, p < 0.01), 2‑h stimulated glucose levels during the OGTT (ρ = -0.18, p < 0.01), HbA1c levels (ρ = -0.13, p < 0.05), FLI and BMI in prediabetic males; however, no relationship between testosterone and metabolic parameters could be found in prediabetic females.
The increase of testosterone levels in males was related to a more favorable glucose metabolism, including lower HbA1c, lower stimulated glucose levels and higher insulin sensitivity; however, in prediabetic females, testosterone was not related to glucose metabolism.
睾酮在调节葡萄糖代谢中起着重要作用。虽然早期的研究表明它对男性有保护作用,但也有研究报道睾酮对女性的葡萄糖代谢有不利影响;然而,在糖尿病前期患者中,睾酮和葡萄糖代谢之间是否存在性别特异性关系尚未得到详细研究。
本横断面分析调查了 423 名男性和 287 名女性糖尿病前期患者。对他们的代谢特征进行了详细评估,包括口服葡萄糖耐量试验(OGTT)2 小时、糖化血红蛋白(HbA1c)水平、稳态模型评估的胰岛素抵抗指数(HOMA-IR)计算、脂质代谢评估、人体测量参数和脂肪肝指数(FLI)。通过 Spearman 相关检验,我们研究了糖尿病前期个体中睾酮与代谢的性别特异性关系。
在本研究中,糖尿病前期女性(平均年龄 58.6 岁,置信区间 [CI]:57.6 y;59.5 y)的空腹血浆葡萄糖水平较低(104.2 mg/dl [CI:103.0 mg/dl;105.4 mg/dl] 与 106.9 mg/dl [CI:106.0 mg/dl;107.8 mg/dl])和 FLI 较低(49.5 [CI:45.7;53.2] 与 58.8 [CI:55.8;61.8]),但在未来 10 年内发展为显性 2 型糖尿病的风险更高(FINDRISK 评分:17.6 [CI:17.1;18.1] 与 16.1 [CI:15.7;16.5])与糖尿病前期男性相比(平均年龄:58.04 岁 [CI:57.0 y;59.1 y])。睾酮与胰岛素抵抗(HOMA-IR:Spearman's ρ:-0.33,p < 0.01)、OGTT 中 2 小时刺激的葡萄糖水平(ρ = -0.18,p < 0.01)、HbA1c 水平(ρ = -0.13,p < 0.05)、FLI 和 BMI 呈负相关;然而,在糖尿病前期女性中,睾酮与代谢参数之间没有关系。
男性睾酮水平的升高与更有利的葡萄糖代谢有关,包括较低的 HbA1c、较低的刺激葡萄糖水平和更高的胰岛素敏感性;然而,在糖尿病前期女性中,睾酮与葡萄糖代谢无关。